Company news

Tenon Medical, Inc. news in 2024

Tenon Medical, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Tenon Medical Reports Third Quarter 2024 Financial Results

November 12, 2024

Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

October 29, 2024

Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company’s New Catamaran(R) SE SI Joint Fusion System

October 29, 2024

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

October 27, 2024

Tenon Medical(R) Announces Issuance of Three U.S. Patents

October 16, 2024

Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

September 18, 2024

Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

September 16, 2024

Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System

September 11, 2024

Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

September 11, 2024

Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical Investigation Utilizing the Catamaran(R) SI Joint...

September 3, 2024

Tenon Medical Announces 1: 8 Reverse Split

September 3, 2024

Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

August 26, 2024

Tenon Medical Reports Second Quarter 2024 Financial Results

August 12, 2024

Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results

July 29, 2024

Tenon Medical Reports First Quarter 2024 Financial Results

May 13, 2024

Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results

April 29, 2024

Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors

March 27, 2024

Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System

March 25, 2024

Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results

March 11, 2024

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results

February 26, 2024

Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant

February 21, 2024

Tenon Medical, Inc. Raises Approximately $2.6 Million in Series A Preferred Stock

February 20, 2024

Tenon Medical, Inc. Announces Second Adjournment of Special Meeting of Stockholders

January 7, 2024

Calls in 2024